In Vitro And In Vivo Studies Of The Inhibitory Effects Of Emodin Isolated From Polygonum Cuspidatum On Coxsakievirus B-4

Zhao Liu,Fei Wei,Liang-Jun Chen,Hai-Rong Xiong,Yuan-Yuan Liu,Fan Luo,Wei Hou,Hong Xiao,Zhan-Qiu Yang
DOI: https://doi.org/10.3390/molecules181011842
IF: 4.6
2013-01-01
Molecules
Abstract:The lack of effective therapeutics for Coxsackievirus B-4 (CVB4) infection underscores the importance of finding novel antiviral compounds. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is one of the natural anthraquinone derivatives obtained from the root and rhizome of Polygonum cuspidatum. In the present study, the possibility of using emodin as a potential antiviral to treat CVB4 infection was explored in vitro and in mice. Emodin reduced CVB4 entry and replication on Hep-2 cells in a concentration-and time-dependent manner, with a 50% effective concentration (EC50) of 12.06 mu M and selectivity index (SI) of 5.08, respectively. The inhibitory effect of emodin for CVB4 entry and replication was further confirmed by a quantitative real time PCR (qPCR) assay. The results further showed that the mice orally treated with different dosages of emodin displayed a dose dependent increase of survival rate, body weight and prolonged mean time of death (MTD), accompanied by significantly decreased myocardial virus titers and pathologic scores/lesions. Moreover, emodin could inhibit CVB4-induced apoptosis in vitro and in vivo. Our results indicated that emodin could be used as potential antiviral in the post-exposure prophylaxis for CVB4 infection.
What problem does this paper attempt to address?